Exactly. Even the most useless drugs can perform astonishingly well in open-label trials, but then do nothing in double-blind placebo-controlled studies.

The fact that remdesivir did NOTHING in a huge open-label study is therefore very very suspicious and alarming, since it throws shade on the studies previously conducted...